(Reuters) -Eyenovia said on Friday it would terminate a late-stage study for its experimental drug-device combination to treat an eye disease after failing the main goal of slowing the progression of ...
Eyenovia will discontinue a late-stage study for its experimental drug-device combination to treat near-sightedness in children after it failed to slow the condition's progression, sending its shares ...
It’s four answers to four questions. Here we go… 1. Should I avoid rolling my eyes while giving feedback to a coworker? My workplace rarely fires people ...
In what has been a transformative year for ulcerative colitis (UC) treatment, the IL-23 class has solidified its role as a key therapeutic treatment option. With Johnson & Johnson’s Tremfya now ...